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Introduction
Depression is common in people with diabetes. A metaanalysis showed that the odds of depression are almost doubled in people with Type 2 diabetes compared with controls [1] . Although a systematic review concluded that data for Type 1 diabetes were insufficient to draw firm conclusions [2] , a more recent study showed that the prevalence of depression was higher in Type 1 diabetes than in controls [3] . Depression is related to adverse outcomes in people with diabetes, including an increased risk for diabetes complications and mortality [4, 5] . Poor glycaemic control might play a central, mediating role in these associations. A meta-analysis, published in 2000, showed that depression is related to higher HbA 1c levels, with standardized effect sizes in the small to medium range [6] , and other studies have shown that elevated levels of HbA 1c are related to the development of diabetes complications and mortality [7] [8] [9] .
Several longitudinal and intervention studies could not replicate an association between depression and HbA 1c [10] [11] [12] . The inconsistent findings regarding the relationship between depression and HbA 1c may be related to the heterogeneous concept and diagnosis of depression. The diagnosis of depression is based on the frequency and severity of a set of various symptoms. According to the Diagnostic and Statistical Manual, fourth edition (DSM-IV), a diagnosis of a major depressive disorder requires the presence of a minimum of five out of nine symptoms, including at least one of the two core symptoms of depression (depressed mood and diminished interest or pleasure in activities) to be present for at least 2 weeks. These symptoms should be accompanied by others, such as sleeping problems, alterations in movement and problems with concentration. Hence, persons with depression may substantially differ in the depressive symptoms they have. At present, little is known about the association of individual symptoms of depression with HbA 1c . Knowledge of the specific associations between individual depressive symptoms and HbA 1c may identify subsets of people with diabetes requiring specific therapeutic interventions. In addition, it may guide research on aetiology, as the various depressive symptoms might signify different pathophysiological pathways.
The aim of the study is to explore the association of individual symptoms of depression with HbA 1c in a large cohort of outpatients with diabetes. Previous studies indicated that high levels of HbA 1c are related to several indicators for poor sleeping quality in diabetes and fatigue [13, 14] . We therefore hypothesized that a differential relationship exists between depressive symptoms and HbA 1c . We expected higher correlations for somatic depressive symptoms, such as fatigue and appetite problems, because these depressive symptoms reflect symptoms of prolonged hyperglycaemia.
Methods

Recruitment
This study was a secondary analysis of data from a multicentre depression screening research project in the Netherlands, which aimed to test whether screening for depression with subsequent feedback was related to a reduction in depressive symptoms compared with screening without feedback [15] . The study design has been described in more detail elsewhere [15, 16] .
Briefly, a random sample of 2055 outpatients with diabetes was drawn from patient registers of three tertiary diabetic clinics in the Netherlands: (1) 1000 outpatients of the VU University Medical Centre (Amsterdam), (2) 555 outpatients of the Haaglanden Medical Centre (The Hague) and (5) 500 outpatients of the Radboud University Medical Centre (Nijmegen). Patients were eligible for the current study if they were aged ! 18 years and had established diabetes (Type 1 or Type 2). Written consent was obtained from all participants, and the study was approved by the local medical ethics committee. The investigations were carried out in accordance with the principles of the Declaration of Helsinki.
Measurements
Participants received questionnaire booklets by mail in two phases. The first questionnaire booklet contained questions on socio-demographic and lifestyle characteristics. The second questionnaire booklet, which was sent to the participants after having received the first questionnaire, captured depressive symptoms. From the medical records of the patients, the following data were obtained: type of diabetes, duration of diabetes, treatment regimen, presence of microvascular complications, presence of cardiovascular disease, HbA 1c values and blood pressure.
Depressive symptoms
The presence and severity of depressive symptoms were assessed with the nine-item Patient Health Questionnaire (PHQ-9) [17] . This self-report questionnaire includes the nine symptoms of the DSM-IV criteria for a major depressive disorder, i.e. (I) lack of interest, (II) depressed mood, (III) sleeping difficulties, (IV) fatigue, (V) appetite problems, (VI) feelings of worthlessness, (VII) concentration problems, (VIII) psychomotor agitation/retardation and (IX) suicidal ideation. We assessed the presence of each symptom according to the scoring algorithm for the PHQ-9. Each symptom was scored as present if endorsed 'more than half the time' or 'nearly all the time'. Symptom 9 (suicidal ideation) was counted when the symptom was present at all. In addition, we classified our participants into those with and without elevated depressive symptoms using a PHQ-9 cut-off of ! 10 [17] .
HbA 1c
The HbA 1c values were extracted from patients' medical records. Assessments were standardized and conducted within 3 months before completion of the PHQ-9. After 1 year, follow-up HbA 1c values were once more collected. Because HbA 1c was expressed in%, we used the mathematical formula (10.93 9 HbA 1c value in% -23.5) to recode the values in mmol/mol [18] .
Statistical analysis
Only patients with complete data on depressive symptoms and baseline HbA 1c were included in the present analysis. Nine cross-sectional linear regression models were constructed for each individual depressive symptom to assess its association with HbA 1c . In a stepwise approach, we adjusted the nine linear regression models for the following potential confounders: sex, age, education level, ethnicity, insulin treatment, body mass index and smoking. We also studied whether the presence of elevated depressive symptoms (PHQ-9 score ! 10) was related to HbA 1c values in linear regression analysis. In sensitivity analyses, we stratified our analyses for type of diabetes. Furthermore, the linear regression analyses were repeated with (1) the 1-year followup values of HbA 1c and (2) change in HbA 1c from baseline to 1-year follow-up as outcomes. All analyses were conducted in SPSS Statistics, version 17.0. As this study was aimed at exploring associations, we made no adjustments for multiple testing [19] ; P-values < 0.05 were considered as statistically significant. 
Results
Of the 2055 invited patients with diabetes, 966 (47%) completed the first questionnaire, of whom 772 (80%) completed and returned the second questionnaire that captured depressive symptoms. A total of 646 participants had complete data on both HbA 1c values and PHQ-9. Table 1 shows the baseline characteristics of the total sample stratified by diabetes type. In our sample group 49% were female, the mean age was 53.3 (AE 15.1) years, 57% had Type 2 diabetes and 91% were on insulin treatment (Type 1 diabetes: 100%, Type 2 diabetes 84%). Furthermore, 288 participants (45%) had one or more depressive symptoms present on the PHQ-9. Symptoms that were most often reported in the total sample were fatigue, sleeping difficulties, problems with concentration and appetite problems. Participants with Type 2 diabetes reported more sleeping difficulties, problems with concentration and appetite problems compared with participants with Type 1 diabetes.
Overall, mean baseline HbA 1c was 61 AE 14 mmol/mol (7.7 AE 1.3%). For 552 out of 646 participants (85%), 1-year follow-up HbA 1c levels were available and amounted 62 AE 14 mmol/mol (7.8% AE 1.3%). The Pearson correlation between HbA 1c values over time was high (r = 0.78, P < 0.001). The HbA 1c values did not differ for type of diabetes. Figure 1 shows the mean baseline and follow-up values of HbA 1c for the presence and absence of each symptom of the PHQ-9. The presence of each symptom was related to higher HbA 1c levels, but the strength and statistical significance of the relationship varied over symptoms.
Cross-sectional analyses
Univariable linear regression analyses showed a statistically significant correlation between baseline HbA 1c and the symptoms depressed mood, sleeping difficulties, fatigue, appetite problems, feelings of worthlessness and suicidal ideation ( Table 2) . Although elevated depressive symptoms (PHQ-9 score ! 10) were related to baseline HbA 1c (b = 0.12, P = 0.003), some of the individual symptoms showed a stronger association (e.g. sleeping difficulties and appetite problems). After adjustment for several potential demographic, lifestyle and clinical confounders, the following symptoms remained significantly related to higher baseline HbA 1c levels ( Table 2) : depressed mood, sleeping difficulties, appetite problems and suicidal ideation. Reporting elevated depressive symptoms (PHQ-9 score ! 10) was also positively associated with HbA 1c (b = 0.10, P = 0.009), but more weakly than some of the individual symptoms (e.g. sleeping difficulties and appetite problems). For those with Type 1 diabetes, the symptoms depressed mood, sleeping difficulties, appetite problems, concentration problems, and suicidal ideation were related to higher baseline HbA 1c levels, whereas for Type 2 diabetes a significant association with baseline HbA 1c was observed for sleeping difficulties, appetite problems and suicidal ideation ( Table 2) . Table 3 shows the relationship between each baseline depressive symptom and the follow-up values of HbA 1c . Multivariable analyses showed that depressed mood, sleeping difficulties, appetite problems and psychomotor agitation/retardation were significantly correlated with HbA 1c levels after 1 year. For participants with Type 1 diabetes, the symptoms sleeping difficulties, appetite problems, concentration problems and psychomotor changes were related to higher follow-up HbA 1c levels, whereas for Type 2 diabetes none of the symptoms were significantly related to follow-up HbA 1c levels. Furthermore, none of the depressed symptoms were related to change in HbA 1c from baseline to 1-year follow-up in the total sample, except for the symptom suicidal ideation (b = 0.12, P = 0.005, fully adjusted analyses). Patients expressing suicidal ideation at baseline showed a decline in HbA 1c over time compared with those without this symptom.
Longitudinal analyses
Discussion
In a large cohort of outpatients with diabetes from three tertiary diabetes clinics, we observed that the presence of several individual depressive symptoms (i.e. depressed mood, sleeping problems, appetite problems and suicidal ideation) was associated with higher concurrent HbA 1c levels. The baseline depressive symptoms depressed mood, sleeping difficulties, and appetite problems were related to higher HbA 1c levels 1 year later. The reported associations were more pronounced in people with Type 1 diabetes. Baseline PHQ-9 symptoms, however, did not predict change in HbA 1c over time, except for a decline in HbA 1c in patients who expressed suicidal ideation at baseline.
A positive association between depression and HbA 1c was observed in a meta-analysis more than 10 years ago for both Type 1 and Type 2 diabetes [6] , but some recent longitudinal and intervention studies could not confirm this [10] [11] [12] . One of the reasons for the inconsistent results regarding the relationship between depression and HbA 1c might be ascribed to the definition of the construct depression. In many studies, depression is treated as a homogeneous syndrome rather than a heterogeneous condition. In analogy with initiatives in psychiatry and psychosomatic research on the 'deconstruction of depression' [20, 21] , it may be important to focus on the differential characteristics of depression, such as different trajectories and symptoms and their relationship with HbA 1c . Furthermore, as the adverse association between depressive symptoms and HbA 1c is not restricted to elevated depression scores [22] , the entire range of depression scores may be of interest. We are aware of one previous study that investigated depressive symptom profiles more closely in relation to HbA 1c . Nefs et al. [23] showed that anhedonia (loss of interest or pleasure), but not depressed mood or anxiety, was related to suboptimal glycaemic control (HbA 1c values above 53 mmol/mol, 7%) in patients with Type 2 diabetes who were treated in primary care settings, and were generally in good glycaemic control. In contrast, we found no significant association between lack of interest and HbA 1c in our sample. Furthermore, we observed a significant association between depressed mood and HbA 1c only among people with Type 1 diabetes and not for Type 2 diabetes.
Our study reports standardized beta-values, which enables comparison of the relative importance of associations. All individual symptoms had correlations with elevated HbA 1c in the hypothesized direction, although the strength of association for some depressive symptoms was negligible. Moreover, the association of some individual depressive symptoms with HbA 1c was more pronounced than that of moderate depression, as indicated by PHQ-9 scores ! 10.
Overall, we observed that sleeping problems were most strongly related to higher HbA 1c values. Sleeping problems are more common in individuals with either Type 1 or Type 2 diabetes compared with those without diabetes [24, 25] . Previous studies showed associations of poor glycaemic control with adverse sleep characteristics in individuals with Type 2 diabetes [13, 14] , but not in individuals with Type 1 diabetes [25] . It remains unclear whether sleeping problems predict or might be a consequence of elevated HbA 1c values, or that one or more common denominators causes both sleep problems and poor glycaemic control. For example, sleep problems may also result from frequent nightly urination owing to high glucose levels, or may be caused by obstructive sleep apnoea, which is prevalent among individuals with Type 2 diabetes. However, reduced duration of sleep has been related to impaired glucoregulation and incident diabetes in prospective studies [26] , supporting the proposition of sleeping problems influencing glycaemic control in Type 2 diabetes. Sleep disorders are related to alterations of various biological systems (e.g. sympathetic nervous system, hypothalamic-pituitary-adrenal axis, inflammation) which are implicated in glucoregulation [27] .
We further observed that appetite problems were related to poor glycaemic control, in particular in participants with Type 1 diabetes. Appetite problems may directly influence HbA 1c values and vice versa. Alternatively, appetite problems might be a result of sleep problems. For example, experimental and observational studies show that sleep loss is related to an up-regulation of the appetite-stimulating hormone ghrelin and down-regulation of the satiety hormone leptin in persons without diabetes [28] . We further observed that two cognitive-affective symptoms of depression (depressed mood, and suicidal ideation) were significantly related to HbA 1c in the total sample. Depressed mood and suicidal ideation may be indicators for a more severe type of depression. They may be related to HbA 1c mainly because of poorer self-care aspects (e.g. taking prescribed medications), although biological changes are also possible. The relationship of suicidal ideation at baseline with a subsequent decline in HbA 1c was surprising. Possibly, suicidal ideation is linked to concurrent levels of HbA 1c rather than future levels. The severity symptom may have been reduced over time together with HbA 1c , although we lacked follow-up data of this symptom to verify this. Some depressive symptoms (e.g. fatigue, appetite problems) may overlap with symptoms of prolonged hyperglycaemia. McDade et al. [29] , however, showed that the structure of depression and anxiety symptoms is similar across individuals with diabetes and adults in the general community without diabetes. Although the overlapping symptoms of hyperglycaemia and depression may result from glycaemic disturbances, they showed that these symptoms were, nonetheless, strongly associated with mood and distress, and argued that overlapping symptoms should not immediately be attributed to the diabetes disease process [29] .
Because correlations between each symptom and HbA 1c were small, the symptoms will explain only a small part of the variance in HbA 1c . However, the mean difference in HbA 1c between patients with and patients without individual depressive symptoms was up to 6 mmol/mol (0.5%), which is considered a clinically relevant difference.
Strengths of the current study are the large sample size, the use of longitudinal data for HbA 1c , and the inclusion of a mixed sample of people with Type 1 and Type 2 diabetes. Furthermore, we used the items of PHQ-9, which corresponds to the DSM-IV symptoms of major depression. However, limitations of the study should also be acknowledged. First, the PHQ-9 was validated for the construct depression but not for the constructs of each single symptom of depression. Second, the use of the PHQ-9 limited our conclusions regarding the direction of the association as some of its items were double-barrelled. For example, the item 'appetite problems' in PHQ-9 describes both increased and decreased appetite. Similarly, the item on sleeping difficulties describes both insomnia and excessive sleeping. Third, depressive symptoms were only assessed at baseline and not at follow-up, which limits the results of longitudinal analyses. Fourth, it remains possible that the selection of patients with diabetes from tertiary diabetes clinics only, and the low uptake of the postal questionnaire, have biased the associations for diabetes patients in general. Finally, our study had an explorative character, in particular the analyses stratified for Type 1 and Type 2 diabetes, which limits more definitive statements regarding the association between depressive symptoms and HbA 1c .
Patients with elevated HbA 1c values are to be considered an at-risk group for specific depressive symptoms and therefore warrant special attention. HbA 1c is a potential clinical mediator of the relationship between depressive symptoms and diabetes complications [30] . Future prospective studies should be conducted to confirm this proposed mediation, taking into account the heterogeneous phenomenology of depression.
In summary, the heterogeneity of depression may help to explain why some studies found relationships between depression and HbA 1c while others did not, as some symptoms may link more strongly to HbA 1c . We found that depressed mood, sleeping difficulties, appetite problems and suicidal ideation appear to be more strongly related to HbA 1c levels, in particular in individuals with Type 1 diabetes.
Funding sources
The study was funded by the Dutch Diabetes Research Foundation (Diabetesfonds), 2000.00.018. 
